Roles of the complement system in alcohol-induced liver disease

키워드

참고문헌 (61)

1. Merle NS, "Complement system part II : role in immunity", Front Immunol, 6, pp.257~ (2015)
2. Ricklin D, "Complement : a key system for immune surveillance and homeostasis", Nat Immunol, 11, pp.785~797 (2010)
3. Gasque P, "Complement : a unique innate immune sensor for danger signals", Mol Immunol, 41, pp.1089~1098 (2004)
4. Fey G, "Biosynthesis of complement components", Fed Proc, 40, pp.2099~2104 (1981)
5. Wlazlo N, "Activated complement factor 3 is associated with liver fat and liver enzymes : the CODAM study", Eur J Clin Invest, 43, pp.679~688 (2013)
6. Colten HR, "Complement in Health and Disease. Immunology and Medicine. Vol 20", pp.127~158 (1993), Springer
7. Walport MJ, "Complement. First of two parts", N Engl J Med, 344, pp.1058~1066 (2001)
8. Bohlson SS, "Complement proteins C1q and MBL are pattern recognition molecules that signal immediate and long-term protective immune functions", Mol Immunol, 44, pp.33~43 (2007)
9. Wallis R, "Paths reunited : initiation of the classical and lectin pathways of complement activation", Immunobiology, 215, pp.1~11 (2010)
10. Schraufstatter IU, "Complement activation in the context of stem cells and tissue repair", World J Stem Cells, 7, pp.1090~1108 (2015)
11. Fearon DT, "Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement", J Exp Med, 138, pp.1305~1313 (1973)
12. Bajic G, "Complement activation, regulation, and molecular basis for complement-related diseases", EMBO J, 34, pp.2735~2757 (2015)
13. Noris M, "Overview of complement activation and regulation", Semin Nephrol, 33, pp.479~492 (2013)
14. Hajishengallis G, "Novel mechanisms and functions of complement", Nat Immunol, 18, pp.1288~1298 (2017)
15. Ehrnthaller C, "New insights of an old defense system : structure, function, and clinical relevance of the complement system", Mol Med, 17, pp.317~329 (2011)
16. Stephan AH, "The complement system : an unexpected role in synaptic pruning during development and disease", Annu Rev Neurosci, 35, pp.369~389 (2012)
17. Giang J, "Complement activation in inflammatory skin diseases", Front Immunol, 9, pp.639~ (2018)
18. Yiu WH, "Complement C5a inhibition moderates lipid metabolism and reduces tubulointerstitial fibrosis in diabetic nephropathy", Nephrol Dial Transplant, 33, pp.1323~1332 (2018)
19. Schmidt CQ, "Complement and coagulation : so close, yet so far", Blood, 130, pp.2581~2582 (2017)
20. Khan MA, "Complement and macrophage crosstalk during process of angiogenesis in tumor progression", J Biomed Sci, 22, pp.58~ (2015)
21. Roychowdhury S, "An early complement-dependent and TLR-4-independent phase in the pathogenesis of ethanol-induced liver injury in mice", Hepatology, 49, pp.1326~1334 (2009)
22. Barry RE, "Acetaldehyde alone may initiate hepatocellular damage in acute alcoholic liver disease", Gut, 26, pp.1065~1069 (1985)
23. Bavia L, "Complement C5 controls liver lipid profile, promotes liver homeostasis and inflammation in C57BL", 6 genetic background, 2016, pp.221, 822~832
24. Jeon S, "Alcohol effects on hepatic lipid metabolism", J Lipid Res, 61, pp.470~479 (2020)
25. Koteish A, "Animal models of steatosis", Semin Liver Dis, 21, pp.89~104 (2001)
26. Järveläinen HA, "Activation of complement components and reduced regulator expression in alcoholinduced liver injury in the rat", Clin Immunol, 105, pp.57~63 (2002)
27. Bykov I, "Complement C3 contributes to ethanol-induced liver steatosis in mice", Ann Med, 38, pp.280~286 (2006)
28. Pritchard MT, "Differential contributions of C3, C5, and decayaccelerating factor to ethanol-induced fatty liver in mice", Gastroenterology, 132, pp.1117~1126 (2007)
29. Galligan JJ, "Oxidative stress and the er stress response in a murine model for early-stage alcoholic liver disease", J Toxicol, 2012, pp.207594~ (2012)
30. Leung TM, "CYP2E1 and oxidant stress in alcoholic and nonalcoholic fatty liver disease", J Hepatol, 58, pp.395~398 (2013)
31. Louvet A, "Alcoholic liver disease : mechanisms of injury and targeted treatment", Nat Rev Gastroenterol Hepatol, 12, pp.231~242 (2015)
32. Zhong F, "Complement C3activation regulates the production of tRNA-derived fragments GlytRFs and promotes alcohol-induced liver injury and steatosis", Cell Res, 29, pp.548~561 (2019)
33. Wang HJ, "Inflammation in alcoholic liver disease", Annu Rev Nutr, 32, pp.343~368 (2012)
34. Smathers RL, "Soluble IgM links apoptosis to complement activation in early alcoholic liver disease in mice", Mol Immunol, 72, pp.9~18 (2016)
35. McCullough RL, "Differential contribution of complement receptor C5aR in myeloid and non-myeloid cells in chronic ethanolinduced liver injury in mice", Mol Immunol, 75, pp.122~132 (2016)
36. Cohen JI, "Complement and alcoholic liver disease : role of C1q in the pathogenesis of ethanol-induced liver injury in mice", Gastroenterology, 139, pp.664~674.e1 (2010)
37. Shen H, "Increased activity of the complement system in the liver of patients with alcoholic hepatitis", Exp Mol Pathol, 97, pp.338~344 (2014)
38. French SW, "Mallory-Denk body pathogenesis revisited", World J Hepatol, 2, pp.295~301 (2010)
39. Liu H, "TLR3", 4signaling is mediated via the NFκB-CXCR4, Exp Mol Pathol, pp.2014, 97[DOI]
40. Raby AC, "TLR activation enhances C5a-induced pro-inflammatory responses by negatively modulating the second C5a receptor, C5L2", Eur J Immunol, 41, pp.2741~2752 (2011)
41. McCullough RL, "Complement Factor D protects mice from ethanol-induced inflammation and liver injury", Am J Physiol Gastrointest Liver Physiol, 315, pp.G66~G79 (2018)
42. Fan X, "Diagnostic and prognostic significance of complement in patients with alcohol-associated hepatitis", Hepatology (2020)[DOI]
43. Hillebrandt S, "Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans", Nat Genet, 37, pp.835~843 (2005)
44. Finlayson ND, "Significance of serum complement levels in chronic liver disease", Gastroenterology, 63, pp.653~659 (1972)
45. Potter BJ, "Serum complement in chronic liver disease", Gut, 14, pp.451~456 (1973)
46. Potter BJ, "Profiles of serum complement in patients with hepatobiliary diseases", Digestion, 18, pp.371~383 (1978)
47. Ellison RT 3rd, "Complement levels in patients with hepatic dysfunction", Dig Dis Sci, 35, pp.231~235 (1990)
48. Deng Y, "Complement 5a is an indicator of significant fibrosis and earlier cirrhosis in patients chronically infected with hepatitis B virus", Infection, 45, pp.75~81 (2017)
49. Behairy BE, "Serum complement C4a and its relation to liver fibrosis in children with chronic hepatitis C", World J Hepatol, 5, pp.445~451 (2013)
50. Baumann M, "Serum C3 complement concentrations correlate with liver function in patients with liver cirrhosis", Hepatogastroenterology, 51, pp.1451~1453 (2004)
51. Ferrín G, "Plasma protein biomarkers of hepatocellular carcinoma in HCV-infected alcoholic patients with cirrhosis", PLoS One, 10, pp.e0118527~ (2015)
52. Homann C, "Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality", Gut, 40, pp.544~549 (1997)
53. Gluud C, "Circulating immune complexes and complement concentrations in patients with alcoholic liver disease", J Clin Pathol, 35, pp.380~384 (1982)
54. Fox RA, "The serum concentration of the third component of complement beta-1C-beta-1A in liver disease", Gut, 12, pp.574~578 (1971)
55. Thorgersen EB, "The role of complement in liver injury, regeneration, and transplantation", Hepatology, 70, pp.725~736 (2019)
56. Varela JC, "Complement : an overview for the clinician", Hematol Oncol Clin North Am, 29, pp.409~427 (2015)
57. Wu G, "Complement regulator CD59 protects against atherosclerosis by restricting the formation of complement membrane attack complex", Circ Res, 104, pp.550~558 (2009)
58. Fujita E, "Inactivation of C5a anaphylatoxin by a peptide that is complementary to a region of C5a", J Immunol, 172, pp.6382~6387 (2004)
59. Otto M, "C5a mutants are potent antagonists of the C5a receptor(CD88)and of C5L2 : position 69 is the locus that determines agonism or antagonism", J Biol Chem, 279, pp.142~151 (2004)
60. Conway EM, "Thrombomodulin and its role in inflammation", Semin Immunopathol, 34, pp.107~125 (2012)
61. Delvaeye M, "Thrombomodulin mutations in atypical hemolytic-uremic syndrome", N Engl J Med, 361, pp.345~357 (2009)

관련 논문AI추천